Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.